Chronic Myeloproliferative Neoplasm Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Research Study in Healthy Volunteers or Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
Conditions:  Chronic Myeloproliferative Disorders;  Fanconi Anemia;  Multiple Myeloma and Plasma Cell Neoplasm;  Myelodysplastic/Myeloproliferative NeoplasmsInterventions:  Genetic: microarray analysis;  Genetic: polyacrylamide gel electrophoresis;  Genetic: polymerase chain reaction;  Genetic: protein expression analysis;  Genetic: reverse transcriptase-polymerase chain reaction;  Genetic: western blotting;  Other: chromatography;  Other: high performance liquid chromatography;  Other: immunoenzyme techniqueSponsors:  OHSU Knight Cancer Institute;  NationalÂ...
Source: ClinicalTrials.gov - May 9, 2009 Category: Research Source Type: clinical trials
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions:  Brain and Central Nervous System Tumors;  Chronic Myeloproliferative Disorders;  Leukemia;  Lymphoma;  Lymphoproliferative Disorder;  Multiple Myeloma and Plasma Cell Neoplasm;  Myelodysplastic Syndromes;  Myelodysplastic/Myeloproliferative Neoplasms;  Unspecified Adult Solid Tumor, Protocol SpecificIntervention:  Other: educational interventionSponsors:  Case Comprehensive Cancer Center;  Case Comprehensive Cancer Center;  National Cancer Institute (NCI)Completed - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2008 Category: Research Source Type: clinical trials
T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
Conditions:  Chronic Myeloproliferative Disorders;  Leukemia;  Lymphoma;  Multiple Myeloma and Malignant Plasma Cell Neoplasms;  Myelodysplastic Syndromes;  Precancerous/Nonmalignant Condition;  Secondary MyelofibrosisInterventions:  Biological: peripheral blood lymphocyte therapy;  Drug: cyclophosphamide;  Drug: tacrolimus;  Procedure: allogeneic hematopoietic stem cell transplantation;  Procedure: peripheral blood stem cell transplantation;  Radiation: total-body irradiationSponsors:  The Cleveland Clinic;  National Cancer Institute (NCI)Active, not recruiting - verified...
Source: ClinicalTrials.gov - January 1, 2008 Category: Research Source Type: clinical trials
T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
Conditions:  Chronic Myeloproliferative Disorders;  Leukemia;  Lymphoma;  Multiple Myeloma and Malignant Plasma Cell Neoplasms;  Myelodysplastic Syndromes;  Precancerous/Nonmalignant Condition;  Secondary MyelofibrosisInterventions:  Biological: peripheral blood lymphocyte therapy;  Drug: cyclophosphamide;  Drug: tacrolimus;  Procedure: allogeneic hematopoietic stem cell transplantation;  Procedure: peripheral blood stem cell transplantation;  Radiation: total-body irradiationSponsors:  The Cleveland Clinic;  The Cleveland Clinic;  National Cancer Institute (NCI)Active...
Source: ClinicalTrials.gov - January 1, 2008 Category: Research Source Type: clinical trials
